Determination of coagulation status as well as circulating levels of complement and inflammation markers in patients with chronic urticaria during acute attack and in remission stage
[1]梁碧华, 肖常青, 林路洋, 等.凝血、抗凝血以及纤溶系统与荨麻疹发病的关系.中国麻风皮肤病杂志,2010,26(2):102-104[2]Ota S, Wada H, Abe Y, .Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis.Clin Appl Thromb Hemost,2008,14(3):279-285[3]Cugno M, Marzano AV, Tedeschi A, et al.Expression of t2 factor by eosinophils in patients with chronic urticaria.Int Arch Allergy Immunol,2009,148(2):170-174[4]Asero R, Tedeschi A, Coppola R, et al.Activation of the t3 factor pathway of blood coagulation in patients with chronic urticaria.J Allergy Clin Immunol,2007,119(3):705-710[5]Fujii K, Usuki A, Kan-No Y, et al.Elevation of circulating thrombin-antithrombin III complex and fibrin degradation products in urticaria: a laboratory finding unrelated to intravascular coagulopathy.J Dermatol,2008,35(5):308-310[6]Kaplan AP, Greaves M.Pathogenesis of chronic urticaria.Clin Exp Allergy,2009,39(6):777-787[7]Asero R, Tedeschi A, Riboldi P, et al.Severe chronic urticaria is associated with elevated plasma levels of D-dimer.Allergy,2008,63(2):176-180[8]Takahagi S, Mihara S, Iwamoto K, et al.Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria.Allergy,2010,65(5):649-656